Ledger.Open graph →
SEC Form D · Amendment · filed November 30, 2020

Appello Pharmaceuticals, Inc

Offering
$15.6M
Sold
$15.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
NASHVILLE, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Christopher P. Rand · Nashville, TNExecWilliam P. Slattery · New York, NYDirectorBrian Laden · Cleveland, OHExec · DirectorHowie P. Furst · New York, NYDirectorJoseph P. Cook, Jr · Nashville, TNDirectorJeff P. Conn · Nashville, TNDirectorSimon A. Lorne · New York, NYExec · DirectorKevin A. Byrne · New York, NYDirectorIan J. Lee · Mountain View, CAExecHowie P. Furst · New York, NYDirectorDavid R. Osborn · Austin, TXDirectorSean Powers · Lexington, SCDirectorVaughn Bryson · Vero Beach, FLDirectorJohn J. Ockerbloom · Hartford, CTExecSuhaimi Bin Zainul Abidin · Singapore, U0DirectorYael Weiss · San Mateo, CAExec · DirectorShalini Sharp · San Mateo, CADirectorCamille Samuels · San Mateo, CADirectorMarten Steen · San Mateo, CADirectorVaughn Bryson · Chapel Hill, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗